Table 3.
Eradication rate of triple tailored therapy among treatment‐naive pediatric patients in Slovenia, 2011‐2014
| Parameters | Eradication | Univariate logistic regression | ||
|---|---|---|---|---|
| Success | Failure | |||
| n (%) | n (%) | OR (95% CI) | P‐value | |
| Number of patients | 61 (85.9) | 10 (14.1) | ||
| Gender (n=71) | ||||
| Male | 20 (83.3) | 4 (16.7) | 1 (ref) | |
| Female | 41 (87.2) | 6 (12.8) | 1.37 (0.35‐5.40) | .66 |
| Age groups (n=71) | ||||
| 1‐11 y | 20 (80.0) | 5 (20.0) | 1 (ref) | |
| 12‐18 y | 41 (89.1) | 5 (10.9) | 2.05 (0.53‐7.91) | .30 |
| Duration of treatment (n=68) | ||||
| 7 or 10 d | 16 (88.9) | 2 (11.1) | 1 (ref) | |
| 14 d | 42 (84.0) | 8 (16.0) | 0.66 (0.13‐3.43) | .62 |
| Antimicrobial therapy | ||||
| Without Clarithromycin (CLA) | 18 (85.7) | 3 (14.3) | 1 (ref) | |
| With CLA | 43 (86.0) | 7 (14.0) | 0.98 (0.23‐4.21) | .98 |
| Without metronidazole (MET) | 43 (17.3) | 9 (82.7) | 1 (ref) | |
| With MET | 18 (94.7) | 1 (5.3) | 3.77 (0.44‐31.96) | .22 |